Balancing benefit and bleeding risk of antithrombotic agents in the individual patient with an acute coronary syndrome.
Van de Werf
Frans
F
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D012307:Risk Factors
D005343:Fibrinolytic Agents